Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.0.2. The older Revision: v3.0.1 tag and the Back to Top element have been removed, and the MedlinePlus Genetics topic 'Melanoma' has been deleted.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated to include information on Melanoma under MedlinePlus Genetics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as recent publications related to pembrolizumab and melanoma, while removing outdated location details and certain related topics.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.12, indicating a revision in the content.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
- Check53 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.